AI assistant
Vivimed Labs Ltd. — Board/Management Information 2020
Aug 13, 2020
61575_rns_2020-08-13_840fdece-4545-4069-9113-e78ab665e465.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Date: 13.08.2020

To BSE Limited P.J.Towers, Dalal Street, Mumbai - 400001 BSE - Code: 532660
National Stock Exchange of India Ltd. Exchange Plaza,Plot no. CIl, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 NSE- Symbol: VIVIMEDLAB
Dear Sir/Madam,
Sub: Intimation on reappointment of Managing Director, Whole time Directors, Director & Independent Director of the Company.
Ref: Regulation 30 read with Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Regulations").
With reference to the above cited Regulations and other applicable provisions, we would like to inform you that, the Board of Directors of the Company, on Thursday, August 13, 2020, have approved the following:
- Re-appointment of Mr.Santosh Varalwar (DIN: 00054763) as the managing director of the Company, for a term of5 years, w.e.f August 14,2020.
Mr.Santosh Varalwar is not debarred from holding the office of a Director by virtue of any SEBI order or any other authority.
- Re-appointment of Mr.Sandeep Varalwar (DIN: 01682951 as the whole time director of the Company, for a term of 5 years, w.e.f August 14, 2020.
Mr.Sandeep Varalwar is not debarred from holding the office of a Director by virtue of any SEBI order or any other authority.
- Re-appointment of Mr.Manohar Rao Varalwar (DIN: 00059815) as the whole time director of the Company, for a term of5 years, w.e.f August 14,2020.
Mr.Manohar Rao Varalwar is not debarred from holding the office of a Director by virtue of any SEBI order or any other authority.
- Re-appointment of Mr.Subhash Varalwar (DIN: 00054789) as the director liable to retire by rotation.
Mr. Subhash Varalwar is not debarred from holding the office of a Director by virtue of any SEBI order or any other authority.
- Re-appointment of Mrs.Umanath Varahabhotla (DIN: 06539204) as an independent director (2nd term) of the Company, for a term of 5 years.
Mrs.Umanath Varahabhotla is not debarred from holding the office of a Director by virtue of any SEBI order or any other authority.

- Payment of not more than 1 % commission out of profits to non executive lindependent directors.
The Company will obtain the approval of the shareholders (in ensuing AGM) with respect to above items in due course.
Further, the additional details required under the Regulations are enclosed herewith.
Kindly take this on record.
Thanking you, For Vivimed Labs Limited
Company Secretary
@J K. Yugandhar
Additional details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
| SI. No. | Details required | Particulars |
|---|---|---|
| 1 | Reason for change | Re-appointment as a Managing director of the Company after completion of the 5 years |
| 2 | Date and term of appointmentIcessation | Re-appointment with effect from August 14, 2020 for a term of 5 years. |
| 3 | Brief profile(in case of appointment) | Mr.Santosh Varalwar aged 58 years is a Management Graduate. He is the driving forcebehind the phenomenal growth of Vivimed Labs Limited. He worked in ShippingCorporation of India (SCI) and had an opportunity to understand in depth mercantile tradeand had immense global exposure, which helped him subsequently to focus on internationalmarketing. He served Mercantile Marine for about seven years before embarking on a highlysuccessful entrepreneurial journey. He has played an active role in VVS Pharmaceuticalsfrom the year 1985 and later on expanded the business to manufacture of API's by acquiringEMGI Pharmaceuticals and Chemicals Private Limited, Bidar, which was later converted intoa public limited company and named as Vivimed Labs Limited. Vivimed Labs Limited waslisted on BSEINSE in the year 2005 and the public issue was all time success having beenoversubscribed 40 times. Since then, he steered the Company to various successfulmilestones and aptly merged VVS Pharmaceuticals in the year to consolidate and create aglobal entity. In the years 2008 and 2009 under his leadership, the Company successfullyacquired two overseas companies namely James Robinson Europe Limited (now VivimedLabs Europe Limited, UK) and Har -Met International Inc, US. In November, 2011, MrSantosh Varalwar successfully led USD 55 million of the 75-year old prestigious Barcelona,Spain based API firm Uquifa. In the year 2013, acquired two Indian companies namelyVivimed Labs (Alathur) Pvt Ltd and Finoso Pharma Pvt Ltd.in 2018 aquired hungary basedSoneas group |
| 4 | Disclosure of relationships betweenDirectors | Mr.Santosh Varalwar is the son of Mr.Manohar Rao Varalwar, Brother of Mr.SandeepVaralwar and relative of Mr.Subhash Varalwar |
1. Re-appointment of Mr.Santosh Varalwar (DIN: 00054763) as the Managing director

| Sl. No. | Details required | Particulars |
|---|---|---|
| 1 | Reason for change | Re-appointment as a whole time director of the Company after completion of 5 years. |
| 2 | Date and term of appointmentIcessation | Re-appointment with effect from August 14, 2020 for a term of 5 years. |
| 3 | Brief profile(in case of appointment) | Mr.Sandeep Varalwar, aged 51 years has completed his Graduation in B.Pharmacy. AfterIcompletion of graduation, he gained more than 25 years of rich experience in manufacturing Iand marketing divisions of Pharma industry.He is the main strength behind the growth of Pharma division of the Company and took anactive role in VVS Pharmaceuticals and Chemicals Pvt. Ltd. After the VVS merger with |
| Vivimed Labs Limited.II | ||
| 4 | Disclosure of relationships betweenDirectors | Mr.Sandeep Varalwar is the Son of Mr.Manohar Rao Varalwar, Brother of Mr.SantoshVaralwar, relative of Mr.Subhash Varalwar---~ ~ |
2. Re-appointment of Mr.Sandeep Varalwar (DIN: 01682951) as the whole time director

| Sl. No. | Details required | Particulars |
|---|---|---|
| 1 | Reason for change | Re-appointment as a whole time director of the Company after completion of 5 years. |
| 2 | Date and term of appointmentIcessation | Re-appointment with effect from August 14, 2020 for a term of 5 years. |
| 3 | Brief profile(in case of appointment) | Dr.V.Manohar Rao aged 84 years, Retired as Joint Director of "The Veterinary Biologicaland Research Institute" (VBRI), has done his post-graduation in Veterinary Sciences fromEdinburgh University, U.K. He has more than 31 years experience in The MunicipalCorporation of Hyderabad and Department of Animal Husbandry, Government of AndhraPradesh. During his tenure with Department of Animal Husbandry, he was involved inadministration and production of various vaccines for livestock and poultry. He worked as aspecial officer for Meat and Poultry Department Corporation Andhra Pradesh GovernmentEnterprises.He conceptualised and started VVS Pharmaceuticals and Chemicals Pvt. Ltd. (VVS), (Nowstands merged with Vivimed Labs Limited). He is mainly responsible for developing aSophisticated and well-equipped in-house Quality Control and introduced various costcontrol systems in production process. His expertise, knowledge and vision helped VVS totransform from a Biological Processing Unit into a Pharmaceutical Manufacturing Unit formanufacturing of Liquid Orals, Tablets, Capsules, Ointments etc. |
| 4 | Disclosure of relationships betweenDirectors | Mr.Manohar Rao Varalwar is the Father of Mr.Santosh Varalwar and Mr.Sandeep Varalwar,Brother of Mr.Subhash Varalwar |
- - --- --.- .1.- - - -------- -- ------------ - ----- ----- ------_. --- ,- -- .-- - - - - ---/ - .. - ---- ._---- ---- ---- - ----

| Sl. No. | Details required | Particulars |
|---|---|---|
| 1 | Reason for change | Re-appointment as the director liable to retire by rotation in ensuing AGM |
| 2 | Date and term of appointmentIcessation | Re-appointment with effect from the date of ensuing AGM. |
| 3 | Brief profile(in case of appointment) | Mr.Subhash Varalwar, aged 72 years is a Post Graduate in Chemical Engineering and aManagement Graduate from Leeds University, U.K. After his post graduation he joined TheFertilizer Corporation of India (FCI) in 1974 as Asst. Project Engineer (Chemical). He heldvarious positions in FCI and worked on various areas like designing and commissioning offertilizer plant, production etc. He resigned from FeI in 1989 to join Vivimed. Mr.Subhashbrings along with him an exposure to various aspects of Industrial Management, includingproduction, planning and commissioning, gained from 15 years of his career span with FCr.Mr. Subhash is responsible for Technology and New Product Development in the chemicalsegment of the Company. He also heads Production, Quality control and R&D function. Hesuccessfully led the technical integration teams of UK/India after acquisition of JamesRobinson Limited and has successfully implemented the stringent regulatory compliancesacross all its manufacturing operations globally. |
| 4 | Disclosure of relationships betweenDirectors-- | Mr.Subhash Varalwar is the Uncle of Mr.Santosh Varalwar and Mr.Sandeep Varalwar, ;Brother of Mr.Manohar Rao Varalwar |
4. Re-appointment of Mr.Subhash Varalwar (DIN: 00054789) as the director liable to retire by rotation

| Sl. No. | Details required | Particulars |
|---|---|---|
| 1 | Reason for change | Re-appointment as an Independent Director of the Company after completion of first term. |
| 2 | Date and term of appointmentIcessation | Re-appointment with effect from 32M AGM to 3ih AGM (5 years). |
| 3 | Brief profile(in case of appointment) | Mrs.Umanath Varahabhotla aged 58 is a Doctorate (Ph.D) in Business Administration, Shehas 27+ years of experience in Healthcare, Hospital systems management, Corporate SocialResponsibility. Creating organizational systems, processes and SoPs from Conceptualizationto Operationalization for piloting and scaling-up of strategically important initiatives.Acknowledged to have built organizations and people. Served as Start-up incubator -LVP,EMRI, ELBIT, Health & CSR at Athena Energy. Vice-president at Tata Business SupportServices, CEO AT Park Specialties Hospitals, Lead Partner -Alliances & Partnerships(Corporate Center) at EMRI, CEO at Elbit Medical Diagnostics Ltd, Administrator AT L VPrasad Eye Institute |
| 4 | Disclosure of relationships betweenDirectors | Mrs.Umanath Varahabhotla is not related to any of the Directors or Promoters of theCompany. |
5. Re-appointment of Mrs.Umanath Varahabhotla (DIN: 06539204) as an independent director (20d term)
For Vivimed Labs Limited
:t Company Secretary
